{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:39:25Z","timestamp":1786991965843,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T00:00:00Z","timestamp":1701475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jdcr.2023.11.023","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T12:29:02Z","timestamp":1701952142000},"page":"20-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Upadacitinib as a treatment for co-existent allergic contact dermatitis and psoriasis"],"prefix":"10.1016","volume":"44","author":[{"given":"Peter Yi","family":"Ch\u2019en","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Al-Saedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9735-0100","authenticated-orcid":false,"given":"Eingun James","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2023.11.023_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","article-title":"Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?","volume":"48","author":"Guttman-Yassky","year":"2017","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"10.1016\/j.jdcr.2023.11.023_bib2","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jdv.16246","article-title":"Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review","volume":"34","author":"Al-Janabi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jdcr.2023.11.023_bib3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jaad.2021.05.013","article-title":"Development of psoriasis during treatment with dupilumab: a systematic review","volume":"86","author":"Brumfiel","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2023.11.023_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.alit.2017.02.015","article-title":"Roles of alternatively activated M2 macrophages in allergic contact dermatitis","volume":"66","author":"Suzuki","year":"2017","journal-title":"Allergol Int"},{"issue":"5","key":"10.1016\/j.jdcr.2023.11.023_bib5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/ced.15052","article-title":"Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?","volume":"47","author":"Megna","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2023.11.023_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/09546634.2019.1689227","article-title":"Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review","volume":"32","author":"Hendricks","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.jdcr.2023.11.023_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cod.14234","article-title":"Tofacitinib in refractory Parthenium-induced airborne allergic contact dermatitis","volume":"88","author":"Muddebihal","year":"2023","journal-title":"Contact Dermatitis"},{"issue":"6","key":"10.1016\/j.jdcr.2023.11.023_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/cod.14204","article-title":"Occupational airborne allergic contact dermatitis to invasive Compositae species treated with abrocitinib: a case report","volume":"87","author":"Baltazar","year":"2022","journal-title":"Contact Dermatitis"},{"issue":"13","key":"10.1016\/j.jdcr.2023.11.023_bib9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa2022516","article-title":"Trial of upadacitinib and adalimumab for psoriatic arthritis","volume":"384","author":"McInnes","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jdcr.2023.11.023_bib10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/ced.15104","article-title":"Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib","volume":"47","author":"Ferrucci","year":"2022","journal-title":"Clin Exp Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623004459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623004459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T11:03:46Z","timestamp":1718881426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623004459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":10,"alternative-id":["S2352512623004459"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.11.023","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upadacitinib as a treatment for co-existent allergic contact dermatitis and psoriasis","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}